

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.45145947 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.45145947 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.44526673 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.39668857 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.39668857 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 4.11468561 |
| 7 | actin-mediated cell contraction (GO:0070252) | 4.03394188 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 3.97950229 |
| 9 | fatty acid transmembrane transport (GO:1902001) | 3.95935578 |
| 10 | urea cycle (GO:0000050) | 3.94753532 |
| 11 | urea metabolic process (GO:0019627) | 3.94753532 |
| 12 | carnitine shuttle (GO:0006853) | 3.89156078 |
| 13 | cellular ketone body metabolic process (GO:0046950) | 3.88655859 |
| 14 | cysteine metabolic process (GO:0006534) | 3.88575197 |
| 15 | kynurenine metabolic process (GO:0070189) | 3.82971415 |
| 16 | lysine catabolic process (GO:0006554) | 3.82053469 |
| 17 | lysine metabolic process (GO:0006553) | 3.82053469 |
| 18 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.80890973 |
| 19 | aromatic amino acid family catabolic process (GO:0009074) | 3.78430848 |
| 20 | plasma membrane repair (GO:0001778) | 3.75105779 |
| 21 | glyoxylate metabolic process (GO:0046487) | 3.68953095 |
| 22 | regulation of fibrinolysis (GO:0051917) | 3.67756675 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 3.56559706 |
| 24 | regulation of protein activation cascade (GO:2000257) | 3.54682351 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 3.54049477 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 3.53615664 |
| 27 | nucleobase catabolic process (GO:0046113) | 3.52929803 |
| 28 | bile acid biosynthetic process (GO:0006699) | 3.46504957 |
| 29 | complement activation, alternative pathway (GO:0006957) | 3.45716432 |
| 30 | homocysteine metabolic process (GO:0050667) | 3.45356217 |
| 31 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.44411639 |
| 32 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.42782630 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 3.42129945 |
| 34 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.40332863 |
| 35 | sarcomere organization (GO:0045214) | 3.40183227 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 3.39825359 |
| 37 | protein carboxylation (GO:0018214) | 3.34294820 |
| 38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.34294820 |
| 39 | regulation of complement activation (GO:0030449) | 3.33440221 |
| 40 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.33214539 |
| 41 | glutamate metabolic process (GO:0006536) | 3.31788353 |
| 42 | lymphangiogenesis (GO:0001946) | 3.30313343 |
| 43 | regulation of skeletal muscle contraction (GO:0014819) | 3.30100903 |
| 44 | ketone body metabolic process (GO:1902224) | 3.28958910 |
| 45 | negative regulation of cholesterol transport (GO:0032375) | 3.21506922 |
| 46 | negative regulation of sterol transport (GO:0032372) | 3.21506922 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.21250569 |
| 48 | triglyceride homeostasis (GO:0070328) | 3.18659908 |
| 49 | acylglycerol homeostasis (GO:0055090) | 3.18659908 |
| 50 | indole-containing compound catabolic process (GO:0042436) | 3.18377982 |
| 51 | indolalkylamine catabolic process (GO:0046218) | 3.18377982 |
| 52 | tryptophan catabolic process (GO:0006569) | 3.18377982 |
| 53 | regulation of cholesterol esterification (GO:0010872) | 3.17923653 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 3.16736447 |
| 55 | macromolecular complex remodeling (GO:0034367) | 3.16736447 |
| 56 | plasma lipoprotein particle remodeling (GO:0034369) | 3.16736447 |
| 57 | bile acid and bile salt transport (GO:0015721) | 3.16097142 |
| 58 | behavioral response to nicotine (GO:0035095) | 3.14110544 |
| 59 | glucan catabolic process (GO:0009251) | 3.12534431 |
| 60 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.12368586 |
| 61 | drug catabolic process (GO:0042737) | 3.11019605 |
| 62 | epoxygenase P450 pathway (GO:0019373) | 3.10615555 |
| 63 | cellular glucuronidation (GO:0052695) | 3.09507603 |
| 64 | acetyl-CoA metabolic process (GO:0006084) | 3.08570750 |
| 65 | positive regulation of lipid catabolic process (GO:0050996) | 3.07961491 |
| 66 | amino-acid betaine metabolic process (GO:0006577) | 3.07634452 |
| 67 | regulation of cholesterol homeostasis (GO:2000188) | 3.06431869 |
| 68 | glycogen catabolic process (GO:0005980) | 3.06409716 |
| 69 | 2-oxoglutarate metabolic process (GO:0006103) | 3.05655646 |
| 70 | bile acid metabolic process (GO:0008206) | 3.05480729 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 3.04653757 |
| 72 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.03762282 |
| 73 | fibrinolysis (GO:0042730) | 3.00001378 |
| 74 | intestinal cholesterol absorption (GO:0030299) | 2.99953018 |
| 75 | response to muscle activity (GO:0014850) | 2.99316459 |
| 76 | carnitine transmembrane transport (GO:1902603) | 2.98826444 |
| 77 | reverse cholesterol transport (GO:0043691) | 2.98499146 |
| 78 | coenzyme catabolic process (GO:0009109) | 2.96670877 |
| 79 | aspartate family amino acid catabolic process (GO:0009068) | 2.95422596 |
| 80 | phospholipid efflux (GO:0033700) | 2.94653731 |
| 81 | alpha-amino acid catabolic process (GO:1901606) | 2.94432837 |
| 82 | tryptophan metabolic process (GO:0006568) | 2.93906058 |
| 83 | regulation of sequestering of triglyceride (GO:0010889) | 2.93478398 |
| 84 | amino-acid betaine transport (GO:0015838) | 2.92661035 |
| 85 | carnitine transport (GO:0015879) | 2.92661035 |
| 86 | paraxial mesoderm development (GO:0048339) | 2.92391897 |
| 87 | phospholipid homeostasis (GO:0055091) | 2.92042755 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 2.88016010 |
| 89 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.86692509 |
| 90 | cholesterol efflux (GO:0033344) | 2.85422416 |
| 91 | skeletal muscle contraction (GO:0003009) | 2.84122971 |
| 92 | cellular polysaccharide catabolic process (GO:0044247) | 2.82916535 |
| 93 | myofibril assembly (GO:0030239) | 2.81619697 |
| 94 | regulation of bile acid biosynthetic process (GO:0070857) | 2.80743533 |
| 95 | muscle filament sliding (GO:0030049) | 2.79727449 |
| 96 | actin-myosin filament sliding (GO:0033275) | 2.79727449 |
| 97 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.78588396 |
| 98 | sterol homeostasis (GO:0055092) | 2.76851043 |
| 99 | cholesterol homeostasis (GO:0042632) | 2.75454144 |
| 100 | cellular amino acid catabolic process (GO:0009063) | 2.74905867 |
| 101 | uronic acid metabolic process (GO:0006063) | 2.74704845 |
| 102 | glucuronate metabolic process (GO:0019585) | 2.74704845 |
| 103 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.73998345 |
| 104 | aromatic amino acid family metabolic process (GO:0009072) | 2.73832485 |
| 105 | polysaccharide catabolic process (GO:0000272) | 2.73790326 |
| 106 | tyrosine metabolic process (GO:0006570) | 2.73703086 |
| 107 | intestinal absorption (GO:0050892) | 2.73668864 |
| 108 | actin filament-based movement (GO:0030048) | 2.73199843 |
| 109 | positive regulation of fatty acid oxidation (GO:0046321) | 2.70331584 |
| 110 | plasma lipoprotein particle assembly (GO:0034377) | 2.68296928 |
| 111 | alkaloid metabolic process (GO:0009820) | 2.67108995 |
| 112 | cell communication involved in cardiac conduction (GO:0086065) | 2.66631804 |
| 113 | short-chain fatty acid metabolic process (GO:0046459) | 2.66354101 |
| 114 | myoblast fusion (GO:0007520) | 2.62698216 |
| 115 | response to inactivity (GO:0014854) | 2.55758439 |
| 116 | regulation of relaxation of muscle (GO:1901077) | 2.54733486 |
| 117 | regulation of hippo signaling (GO:0035330) | 2.53300429 |
| 118 | regulation of hexokinase activity (GO:1903299) | 2.51490262 |
| 119 | regulation of glucokinase activity (GO:0033131) | 2.51490262 |
| 120 | cardiac myofibril assembly (GO:0055003) | 2.46510995 |
| 121 | dorsal/ventral axis specification (GO:0009950) | 2.45961765 |
| 122 | myotube cell development (GO:0014904) | 2.45951465 |
| 123 | skeletal muscle fiber development (GO:0048741) | 2.45939234 |
| 124 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.42501958 |
| 125 | artery development (GO:0060840) | 2.37809161 |
| 126 | protein K6-linked ubiquitination (GO:0085020) | 2.36955253 |
| 127 | striated muscle contraction (GO:0006941) | 2.34017246 |
| 128 | actomyosin structure organization (GO:0031032) | 2.30888738 |
| 129 | dopaminergic neuron differentiation (GO:0071542) | 2.30049678 |
| 130 | cardiac muscle cell development (GO:0055013) | 2.29514657 |
| 131 | cornea development in camera-type eye (GO:0061303) | 2.28053098 |
| 132 | ribonucleoprotein complex disassembly (GO:0032988) | 2.25583330 |
| 133 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.24913417 |
| 134 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.24468779 |
| 135 | adult heart development (GO:0007512) | 2.23425153 |
| 136 | interkinetic nuclear migration (GO:0022027) | 2.23209441 |
| 137 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.22921544 |
| 138 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.21489706 |
| 139 | muscle contraction (GO:0006936) | 2.19271928 |
| 140 | protein localization to microtubule (GO:0035372) | 2.18142908 |
| 141 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.16870865 |
| 142 | kidney mesenchyme development (GO:0072074) | 2.15272065 |
| 143 | nuclear pore organization (GO:0006999) | 2.12945943 |
| 144 | organelle disassembly (GO:1903008) | 2.12710500 |
| 145 | protein localization to cytoskeleton (GO:0044380) | 2.11121875 |
| 146 | NLS-bearing protein import into nucleus (GO:0006607) | 2.10683050 |
| 147 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.08292223 |
| 148 | ATP synthesis coupled proton transport (GO:0015986) | 2.08292223 |
| 149 | hindbrain development (GO:0030902) | 2.08163808 |
| 150 | regulation of sarcomere organization (GO:0060297) | 2.07552442 |
| 151 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.07433147 |
| 152 | muscle fiber development (GO:0048747) | 2.07267364 |
| 153 | protein localization to microtubule cytoskeleton (GO:0072698) | 2.07157347 |
| 154 | muscle cell fate commitment (GO:0042693) | 2.06538543 |
| 155 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.05145175 |
| 156 | striated muscle cell development (GO:0055002) | 2.04362689 |
| 157 | cardiac cell development (GO:0055006) | 2.04193745 |
| 158 | otic vesicle formation (GO:0030916) | 2.03295877 |
| 159 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.01780866 |
| 160 | respiratory electron transport chain (GO:0022904) | 2.00311843 |
| 161 | muscle tissue morphogenesis (GO:0060415) | 2.00240660 |
| 162 | electron transport chain (GO:0022900) | 2.00175010 |
| 163 | cell migration involved in gastrulation (GO:0042074) | 1.99245132 |
| 164 | neuron fate specification (GO:0048665) | 1.98434674 |
| 165 | hippo signaling (GO:0035329) | 1.98237668 |
| 166 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 1.98009217 |
| 167 | regulation of cardioblast proliferation (GO:0003264) | 1.98009217 |
| 168 | glucan biosynthetic process (GO:0009250) | 1.97632397 |
| 169 | glycogen biosynthetic process (GO:0005978) | 1.97632397 |
| 170 | negative regulation of protein localization to cell surface (GO:2000009) | 1.97409596 |
| 171 | meiotic cell cycle (GO:0051321) | 1.96003845 |
| 172 | regulation of DNA endoreduplication (GO:0032875) | 1.95398902 |
| 173 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 1.95351302 |
| 174 | ventricular septum development (GO:0003281) | 1.94933168 |
| 175 | regulation of cell communication by electrical coupling (GO:0010649) | 1.94375677 |
| 176 | maturation of SSU-rRNA (GO:0030490) | 1.93925098 |
| 177 | skeletal muscle tissue development (GO:0007519) | 1.93464858 |
| 178 | cardiac muscle tissue morphogenesis (GO:0055008) | 1.93310899 |
| 179 | regulation of action potential (GO:0098900) | 1.92641495 |
| 180 | muscle system process (GO:0003012) | 1.92380607 |
| 181 | regulation of translational termination (GO:0006449) | 1.92303620 |
| 182 | embryonic foregut morphogenesis (GO:0048617) | 1.91659416 |
| 183 | regulation of meiosis I (GO:0060631) | 1.91281184 |
| 184 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 1.91241622 |
| 185 | notochord development (GO:0030903) | 1.89793868 |
| 186 | muscle structure development (GO:0061061) | 1.88255196 |
| 187 | neuron fate determination (GO:0048664) | 1.88068537 |
| 188 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 1.87911336 |
| 189 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 1.87663864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.76478528 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.00043072 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.52513978 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49164215 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.48184721 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.64982823 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.62369267 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.59431461 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.44226628 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.37905462 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.31579699 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.25638284 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.25262229 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.18077026 |
| 15 | FUS_26573619_Chip-Seq_HEK293_Human | 2.11674728 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.03389499 |
| 17 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.93518161 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78880129 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.77304258 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73610604 |
| 21 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69757625 |
| 22 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69734759 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69484182 |
| 24 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.68055558 |
| 25 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.67542735 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65874011 |
| 27 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.64789435 |
| 28 | EWS_26573619_Chip-Seq_HEK293_Human | 1.63472560 |
| 29 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.62066694 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57747324 |
| 31 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.55108502 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.54600560 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.53975400 |
| 34 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.52124963 |
| 35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.46137864 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45209926 |
| 37 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44475050 |
| 38 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.41312512 |
| 39 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.38050478 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37489556 |
| 41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.36555898 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36466533 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36096027 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34508846 |
| 45 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33983535 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.33983535 |
| 47 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30935172 |
| 48 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28737564 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24473460 |
| 50 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23899497 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21814693 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20903216 |
| 53 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.19568966 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19226055 |
| 55 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.15429740 |
| 56 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14357297 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12841032 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12776855 |
| 59 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.12432538 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11991797 |
| 61 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.11855253 |
| 62 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10995068 |
| 63 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.10941708 |
| 64 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.10700002 |
| 65 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10134121 |
| 66 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09779999 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09385902 |
| 68 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09349997 |
| 69 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.08748001 |
| 70 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08588613 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.08422531 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08374157 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08177447 |
| 74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07996368 |
| 75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07996368 |
| 76 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07490981 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07229553 |
| 78 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.06784890 |
| 79 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.06644276 |
| 80 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.06644276 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06266481 |
| 82 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.06098426 |
| 83 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05704717 |
| 84 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.05522072 |
| 85 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.04432527 |
| 86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04266108 |
| 87 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03188710 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02705383 |
| 89 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02416525 |
| 90 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02351413 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02005728 |
| 92 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.01527834 |
| 93 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.01242527 |
| 94 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01205575 |
| 95 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01205575 |
| 96 | TBL1_22424771_ChIP-Seq_293T_Human | 1.01030354 |
| 97 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01026109 |
| 98 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.99819534 |
| 99 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98873043 |
| 100 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.98850118 |
| 101 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98785951 |
| 102 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98439345 |
| 103 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97961962 |
| 104 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97951931 |
| 105 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97813732 |
| 106 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.96803954 |
| 107 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94720944 |
| 108 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94719632 |
| 109 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94365246 |
| 110 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.94252191 |
| 111 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94244319 |
| 112 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93361441 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92942134 |
| 114 | JUN_21703547_ChIP-Seq_K562_Human | 0.92818568 |
| 115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92378911 |
| 116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92289454 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92045709 |
| 118 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.91956267 |
| 119 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.91734424 |
| 120 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.91620557 |
| 121 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.91270538 |
| 122 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90633668 |
| 123 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90351713 |
| 124 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.90343610 |
| 125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90068891 |
| 126 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.89944795 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89398833 |
| 128 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.89097125 |
| 129 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89071825 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88918361 |
| 131 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88791271 |
| 132 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.88768365 |
| 133 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87904312 |
| 134 | NFYB_21822215_ChIP-Seq_K562_Human | 0.87812201 |
| 135 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87553930 |
| 136 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87330758 |
| 137 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.86642166 |
| 138 | KDM2B_26808549_Chip-Seq_K562_Human | 0.86050497 |
| 139 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.85752124 |
| 140 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.85568103 |
| 141 | VDR_22108803_ChIP-Seq_LS180_Human | 0.85510867 |
| 142 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85401649 |
| 143 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84258914 |
| 144 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84136871 |
| 145 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83812511 |
| 146 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.83001873 |
| 147 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.82829523 |
| 148 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82688458 |
| 149 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82469953 |
| 150 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.82326014 |
| 151 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.82206300 |
| 152 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.81792519 |
| 153 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.81505912 |
| 154 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81411190 |
| 155 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81409171 |
| 156 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.81406610 |
| 157 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.79695313 |
| 158 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.78960511 |
| 159 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.78525469 |
| 160 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78420854 |
| 161 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.78287477 |
| 162 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78057829 |
| 163 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.78044994 |
| 164 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.77968497 |
| 165 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.77848780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.73107493 |
| 2 | MP0005360_urolithiasis | 5.46996493 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.46977955 |
| 4 | MP0005365_abnormal_bile_salt | 3.62862412 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.13628529 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.82563831 |
| 7 | MP0003252_abnormal_bile_duct | 2.74507683 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.73772435 |
| 9 | MP0005083_abnormal_biliary_tract | 2.65013986 |
| 10 | MP0000751_myopathy | 2.50140738 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.44560698 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.17913811 |
| 13 | MP0004130_abnormal_muscle_cell | 2.13247085 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.03430127 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.01017180 |
| 16 | MP0003890_abnormal_embryonic-extraembry | 1.94804724 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 1.93111950 |
| 18 | MP0006292_abnormal_olfactory_placode | 1.92377581 |
| 19 | MP0000749_muscle_degeneration | 1.81265585 |
| 20 | MP0003646_muscle_fatigue | 1.76581778 |
| 21 | MP0002160_abnormal_reproductive_system | 1.68865561 |
| 22 | MP0005332_abnormal_amino_acid | 1.68475069 |
| 23 | MP0004087_abnormal_muscle_fiber | 1.65251519 |
| 24 | MP0000566_synostosis | 1.63689967 |
| 25 | MP0003718_maternal_effect | 1.62330797 |
| 26 | MP0010030_abnormal_orbit_morphology | 1.59699169 |
| 27 | MP0000747_muscle_weakness | 1.57053952 |
| 28 | MP0004270_analgesia | 1.55069532 |
| 29 | MP0002269_muscular_atrophy | 1.53592481 |
| 30 | MP0009840_abnormal_foam_cell | 1.51872363 |
| 31 | MP0003937_abnormal_limbs/digits/tail_de | 1.51545293 |
| 32 | MP0002796_impaired_skin_barrier | 1.48845786 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.48308035 |
| 34 | MP0005330_cardiomyopathy | 1.47351325 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.43283745 |
| 36 | MP0004036_abnormal_muscle_relaxation | 1.42734133 |
| 37 | MP0002938_white_spotting | 1.41076215 |
| 38 | MP0002118_abnormal_lipid_homeostasis | 1.40904562 |
| 39 | MP0009053_abnormal_anal_canal | 1.40639989 |
| 40 | MP0005620_abnormal_muscle_contractility | 1.40043501 |
| 41 | MP0005451_abnormal_body_composition | 1.39142731 |
| 42 | MP0004084_abnormal_cardiac_muscle | 1.36799639 |
| 43 | MP0000579_abnormal_nail_morphology | 1.33045659 |
| 44 | MP0009250_abnormal_appendicular_skeleto | 1.30357194 |
| 45 | MP0004215_abnormal_myocardial_fiber | 1.29041208 |
| 46 | MP0003868_abnormal_feces_composition | 1.27162689 |
| 47 | MP0000759_abnormal_skeletal_muscle | 1.24094243 |
| 48 | MP0000762_abnormal_tongue_morphology | 1.22776090 |
| 49 | MP0005666_abnormal_adipose_tissue | 1.19660086 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.14922423 |
| 51 | MP0000049_abnormal_middle_ear | 1.14661722 |
| 52 | MP0003283_abnormal_digestive_organ | 1.14544621 |
| 53 | MP0002972_abnormal_cardiac_muscle | 1.13617125 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.13270035 |
| 55 | MP0002106_abnormal_muscle_physiology | 1.12992232 |
| 56 | MP0009384_cardiac_valve_regurgitation | 1.12370228 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.11373512 |
| 58 | MP0000750_abnormal_muscle_regeneration | 1.10702324 |
| 59 | MP0005187_abnormal_penis_morphology | 1.10476850 |
| 60 | MP0004233_abnormal_muscle_weight | 1.09009126 |
| 61 | MP0000609_abnormal_liver_physiology | 1.08625444 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.08287291 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 1.06357896 |
| 64 | MP0003755_abnormal_palate_morphology | 1.05863608 |
| 65 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04656181 |
| 66 | MP0005275_abnormal_skin_tensile | 1.04442081 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.03181206 |
| 68 | MP0008789_abnormal_olfactory_epithelium | 1.02251085 |
| 69 | MP0003119_abnormal_digestive_system | 0.98677716 |
| 70 | MP0002735_abnormal_chemical_nociception | 0.97928454 |
| 71 | MP0003137_abnormal_impulse_conducting | 0.97780845 |
| 72 | MP0005369_muscle_phenotype | 0.96467047 |
| 73 | MP0003329_amyloid_beta_deposits | 0.96441067 |
| 74 | MP0006138_congestive_heart_failure | 0.96241838 |
| 75 | MP0002697_abnormal_eye_size | 0.95770991 |
| 76 | MP0009780_abnormal_chondrocyte_physiolo | 0.95525941 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 0.95524906 |
| 78 | MP0000537_abnormal_urethra_morphology | 0.95084013 |
| 79 | MP0002971_abnormal_brown_adipose | 0.94437741 |
| 80 | MP0003942_abnormal_urinary_system | 0.93930114 |
| 81 | MP0005248_abnormal_Harderian_gland | 0.93787198 |
| 82 | MP0010630_abnormal_cardiac_muscle | 0.93244390 |
| 83 | MP0003195_calcinosis | 0.92812420 |
| 84 | MP0004484_altered_response_of | 0.92527399 |
| 85 | MP0000534_abnormal_ureter_morphology | 0.92245306 |
| 86 | MP0001544_abnormal_cardiovascular_syste | 0.91352514 |
| 87 | MP0005385_cardiovascular_system_phenoty | 0.91352514 |
| 88 | MP0009379_abnormal_foot_pigmentation | 0.89345360 |
| 89 | MP0005670_abnormal_white_adipose | 0.88247945 |
| 90 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87940495 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.87647188 |
| 92 | MP0005623_abnormal_meninges_morphology | 0.87537906 |
| 93 | MP0003136_yellow_coat_color | 0.87302655 |
| 94 | MP0002233_abnormal_nose_morphology | 0.86799013 |
| 95 | MP0001286_abnormal_eye_development | 0.86624784 |
| 96 | MP0000372_irregular_coat_pigmentation | 0.86458826 |
| 97 | MP0004134_abnormal_chest_morphology | 0.86338602 |
| 98 | MP0002084_abnormal_developmental_patter | 0.85500438 |
| 99 | MP0003011_delayed_dark_adaptation | 0.84909870 |
| 100 | MP0003385_abnormal_body_wall | 0.84888973 |
| 101 | MP0001188_hyperpigmentation | 0.84818354 |
| 102 | MP0001293_anophthalmia | 0.84391913 |
| 103 | MP0001661_extended_life_span | 0.84024836 |
| 104 | MP0004043_abnormal_pH_regulation | 0.83936006 |
| 105 | MP0003315_abnormal_perineum_morphology | 0.83695537 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.83333863 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.82771353 |
| 108 | MP0000631_abnormal_neuroendocrine_gland | 0.82439020 |
| 109 | MP0000428_abnormal_craniofacial_morphol | 0.82342245 |
| 110 | MP0008775_abnormal_heart_ventricle | 0.82123590 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82010365 |
| 112 | MP0004142_abnormal_muscle_tone | 0.81628991 |
| 113 | MP0009697_abnormal_copulation | 0.81404874 |
| 114 | MP0002009_preneoplasia | 0.81352584 |
| 115 | MP0003935_abnormal_craniofacial_develop | 0.80432100 |
| 116 | MP0004858_abnormal_nervous_system | 0.79998196 |
| 117 | MP0005389_reproductive_system_phenotype | 0.79024100 |
| 118 | MP0002102_abnormal_ear_morphology | 0.78322997 |
| 119 | MP0003693_abnormal_embryo_hatching | 0.76871351 |
| 120 | MP0004085_abnormal_heartbeat | 0.76294319 |
| 121 | MP0002234_abnormal_pharynx_morphology | 0.75191637 |
| 122 | MP0002177_abnormal_outer_ear | 0.74460923 |
| 123 | MP0005375_adipose_tissue_phenotype | 0.71859763 |
| 124 | MP0005197_abnormal_uvea_morphology | 0.71738149 |
| 125 | MP0001299_abnormal_eye_distance/ | 0.71240774 |
| 126 | MP0000733_abnormal_muscle_development | 0.70914150 |
| 127 | MP0005408_hypopigmentation | 0.70791636 |
| 128 | MP0005334_abnormal_fat_pad | 0.69842643 |
| 129 | MP0000003_abnormal_adipose_tissue | 0.69330330 |
| 130 | MP0003959_abnormal_lean_body | 0.68911144 |
| 131 | MP0006036_abnormal_mitochondrial_physio | 0.68802272 |
| 132 | MP0003941_abnormal_skin_development | 0.68236264 |
| 133 | MP0002108_abnormal_muscle_morphology | 0.67969029 |
| 134 | MP0000604_amyloidosis | 0.67845521 |
| 135 | MP0000462_abnormal_digestive_system | 0.67691725 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.67436482 |
| 137 | MP0000778_abnormal_nervous_system | 0.67336550 |
| 138 | MP0010368_abnormal_lymphatic_system | 0.66725909 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.66393441 |
| 140 | MP0002078_abnormal_glucose_homeostasis | 0.66223408 |
| 141 | MP0004272_abnormal_basement_membrane | 0.65674924 |
| 142 | MP0002733_abnormal_thermal_nociception | 0.64331112 |
| 143 | MP0003566_abnormal_cell_adhesion | 0.61997978 |
| 144 | MP0002734_abnormal_mechanical_nocicepti | 0.61214686 |
| 145 | MP0002332_abnormal_exercise_endurance | 0.59912866 |
| 146 | MP0002127_abnormal_cardiovascular_syste | 0.59151805 |
| 147 | MP0001968_abnormal_touch/_nociception | 0.58704137 |
| 148 | MP0005501_abnormal_skin_physiology | 0.55489203 |
| 149 | MP0000427_abnormal_hair_cycle | 0.55383065 |
| 150 | MP0000538_abnormal_urinary_bladder | 0.55352761 |
| 151 | MP0005448_abnormal_energy_balance | 0.55147796 |
| 152 | MP0000467_abnormal_esophagus_morphology | 0.54251041 |
| 153 | MP0000569_abnormal_digit_pigmentation | 0.53648341 |
| 154 | MP0003191_abnormal_cellular_cholesterol | 0.53189287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.85290970 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.20479740 |
| 3 | Hyporeflexia of lower limbs (HP:0002600) | 4.09753599 |
| 4 | Xanthomatosis (HP:0000991) | 4.03894803 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 3.93111060 |
| 6 | Exercise-induced myalgia (HP:0003738) | 3.90014221 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 3.80914973 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 3.74446231 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.67673626 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 3.65564607 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.63051464 |
| 12 | Hypolipoproteinemia (HP:0010981) | 3.44088636 |
| 13 | Epidermoid cyst (HP:0200040) | 3.39541314 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 3.31616847 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.31269507 |
| 16 | Sudden death (HP:0001699) | 3.21620944 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.12020458 |
| 18 | Myoglobinuria (HP:0002913) | 3.11977062 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.09936586 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.09129008 |
| 21 | Calf muscle hypertrophy (HP:0008981) | 3.07294913 |
| 22 | Increased connective tissue (HP:0009025) | 3.06253866 |
| 23 | Muscle fiber splitting (HP:0003555) | 3.03719444 |
| 24 | Complement deficiency (HP:0004431) | 2.98449678 |
| 25 | Nemaline bodies (HP:0003798) | 2.96005363 |
| 26 | Difficulty running (HP:0009046) | 2.93397982 |
| 27 | Abnormality of the Achilles tendon (HP:0005109) | 2.89386361 |
| 28 | Type 1 muscle fiber predominance (HP:0003803) | 2.83845954 |
| 29 | Ketosis (HP:0001946) | 2.81630409 |
| 30 | Subaortic stenosis (HP:0001682) | 2.76696873 |
| 31 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.76696873 |
| 32 | Prolonged partial thromboplastin time (HP:0003645) | 2.66399336 |
| 33 | Distal arthrogryposis (HP:0005684) | 2.65365184 |
| 34 | Hyperammonemia (HP:0001987) | 2.65052304 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.64785815 |
| 36 | Muscle stiffness (HP:0003552) | 2.64189890 |
| 37 | Ketoacidosis (HP:0001993) | 2.61812643 |
| 38 | Achilles tendon contracture (HP:0001771) | 2.59896210 |
| 39 | Hypoglycemic coma (HP:0001325) | 2.58762807 |
| 40 | Abnormality of the calf musculature (HP:0001430) | 2.57739526 |
| 41 | Absent phalangeal crease (HP:0006109) | 2.52061554 |
| 42 | EMG: myopathic abnormalities (HP:0003458) | 2.52019790 |
| 43 | Ventricular tachycardia (HP:0004756) | 2.51105940 |
| 44 | Difficulty climbing stairs (HP:0003551) | 2.46111611 |
| 45 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43836656 |
| 46 | Hyperglycinuria (HP:0003108) | 2.43743884 |
| 47 | Calcaneovalgus deformity (HP:0001848) | 2.41215601 |
| 48 | Abnormal gallbladder physiology (HP:0012438) | 2.40938198 |
| 49 | Cholecystitis (HP:0001082) | 2.40938198 |
| 50 | Neck muscle weakness (HP:0000467) | 2.38657430 |
| 51 | Abnormality of glycine metabolism (HP:0010895) | 2.37103232 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.37103232 |
| 53 | Myopathic facies (HP:0002058) | 2.36050153 |
| 54 | Myotonia (HP:0002486) | 2.34615720 |
| 55 | Termporal pattern (HP:0011008) | 2.33685633 |
| 56 | Insidious onset (HP:0003587) | 2.33685633 |
| 57 | Skin nodule (HP:0200036) | 2.32996816 |
| 58 | Hypercholesterolemia (HP:0003124) | 2.31138606 |
| 59 | Rhabdomyolysis (HP:0003201) | 2.30390600 |
| 60 | Hyperglycinemia (HP:0002154) | 2.30022617 |
| 61 | Cholelithiasis (HP:0001081) | 2.28408853 |
| 62 | Malnutrition (HP:0004395) | 2.23912722 |
| 63 | Fat malabsorption (HP:0002630) | 2.22687392 |
| 64 | Deformed tarsal bones (HP:0008119) | 2.22673923 |
| 65 | Frequent falls (HP:0002359) | 2.22007557 |
| 66 | Ulnar deviation of the wrist (HP:0003049) | 2.19909258 |
| 67 | Abnormality of complement system (HP:0005339) | 2.18851869 |
| 68 | Round ear (HP:0100830) | 2.18813653 |
| 69 | Hip contracture (HP:0003273) | 2.18807438 |
| 70 | Gout (HP:0001997) | 2.18538746 |
| 71 | Areflexia of lower limbs (HP:0002522) | 2.10593130 |
| 72 | Abnormal gallbladder morphology (HP:0012437) | 2.09788650 |
| 73 | Concave nail (HP:0001598) | 2.07003518 |
| 74 | Neonatal onset (HP:0003623) | 2.06127016 |
| 75 | Abnormal finger flexion creases (HP:0006143) | 2.04095305 |
| 76 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.00051256 |
| 77 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.99420024 |
| 78 | Conjunctival hamartoma (HP:0100780) | 1.99257457 |
| 79 | Rimmed vacuoles (HP:0003805) | 1.98872320 |
| 80 | Back pain (HP:0003418) | 1.98662373 |
| 81 | Decreased subcutaneous fat (HP:0001002) | 1.98302593 |
| 82 | Ventricular fibrillation (HP:0001663) | 1.98132015 |
| 83 | Palpitations (HP:0001962) | 1.96994943 |
| 84 | Bundle branch block (HP:0011710) | 1.96875172 |
| 85 | Syncope (HP:0001279) | 1.96643204 |
| 86 | Type II lissencephaly (HP:0007260) | 1.94857657 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.93974134 |
| 88 | Abnormality of alanine metabolism (HP:0010916) | 1.93974134 |
| 89 | Hyperalaninemia (HP:0003348) | 1.93974134 |
| 90 | Abnormality of the renal cortex (HP:0011035) | 1.89663320 |
| 91 | Hyperglycemia (HP:0003074) | 1.89458873 |
| 92 | Limited hip movement (HP:0008800) | 1.88460172 |
| 93 | Shoulder girdle muscle weakness (HP:0003547) | 1.88363446 |
| 94 | Ventricular arrhythmia (HP:0004308) | 1.88234105 |
| 95 | Asymmetric septal hypertrophy (HP:0001670) | 1.87372333 |
| 96 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.86747614 |
| 97 | Abnormality of purine metabolism (HP:0004352) | 1.83997183 |
| 98 | EMG: neuropathic changes (HP:0003445) | 1.82465569 |
| 99 | Abnormality of the lower motor neuron (HP:0002366) | 1.81485356 |
| 100 | Spinal rigidity (HP:0003306) | 1.79890983 |
| 101 | Ileus (HP:0002595) | 1.76928103 |
| 102 | Delayed gross motor development (HP:0002194) | 1.76597587 |
| 103 | Fibular aplasia (HP:0002990) | 1.76364703 |
| 104 | Myocardial infarction (HP:0001658) | 1.76341609 |
| 105 | Hamartoma of the eye (HP:0010568) | 1.76012298 |
| 106 | Increased variability in muscle fiber diameter (HP:0003557) | 1.75336412 |
| 107 | Renal cortical cysts (HP:0000803) | 1.74446386 |
| 108 | Scapular winging (HP:0003691) | 1.73787489 |
| 109 | Hyperuricemia (HP:0002149) | 1.73421151 |
| 110 | Increased purine levels (HP:0004368) | 1.73421151 |
| 111 | Pheochromocytoma (HP:0002666) | 1.72716444 |
| 112 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.72087360 |
| 113 | Hepatocellular carcinoma (HP:0001402) | 1.72041216 |
| 114 | Ulnar deviation of finger (HP:0009465) | 1.69694284 |
| 115 | Muscular dystrophy (HP:0003560) | 1.69628185 |
| 116 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.69394126 |
| 117 | Limb-girdle muscle atrophy (HP:0003797) | 1.68630072 |
| 118 | Distal lower limb muscle weakness (HP:0009053) | 1.66416579 |
| 119 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.65954563 |
| 120 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.65954563 |
| 121 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.65009633 |
| 122 | Late onset (HP:0003584) | 1.64470761 |
| 123 | Abnormality of the intrinsic pathway (HP:0010989) | 1.64052190 |
| 124 | Lipoatrophy (HP:0100578) | 1.63974381 |
| 125 | Generalized muscle weakness (HP:0003324) | 1.62822185 |
| 126 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.62380871 |
| 127 | Central scotoma (HP:0000603) | 1.61595907 |
| 128 | Proximal tubulopathy (HP:0000114) | 1.59613327 |
| 129 | Hyperkalemia (HP:0002153) | 1.57066539 |
| 130 | Fetal akinesia sequence (HP:0001989) | 1.56533055 |
| 131 | Gowers sign (HP:0003391) | 1.55847508 |
| 132 | Pancreatic cysts (HP:0001737) | 1.55401744 |
| 133 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.54435665 |
| 134 | Hypoplasia of the fovea (HP:0007750) | 1.54435665 |
| 135 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.52766798 |
| 136 | Unilateral renal agenesis (HP:0000122) | 1.51391751 |
| 137 | Fatigable weakness (HP:0003473) | 1.49227352 |
| 138 | Abnormality of the neuromuscular junction (HP:0003398) | 1.49227352 |
| 139 | Cerebellar dysplasia (HP:0007033) | 1.48342990 |
| 140 | Congenital, generalized hypertrichosis (HP:0004540) | 1.46757577 |
| 141 | Coronal craniosynostosis (HP:0004440) | 1.43855519 |
| 142 | Congenital sensorineural hearing impairment (HP:0008527) | 1.43334244 |
| 143 | Chorioretinal atrophy (HP:0000533) | 1.43184093 |
| 144 | Aplasia of the musculature (HP:0100854) | 1.42564059 |
| 145 | Pachygyria (HP:0001302) | 1.42054354 |
| 146 | Molar tooth sign on MRI (HP:0002419) | 1.39663205 |
| 147 | Abnormality of midbrain morphology (HP:0002418) | 1.39663205 |
| 148 | Abnormality of the calcaneus (HP:0008364) | 1.39537930 |
| 149 | Tubular atrophy (HP:0000092) | 1.39494741 |
| 150 | Pancreatic fibrosis (HP:0100732) | 1.39017843 |
| 151 | Knee flexion contracture (HP:0006380) | 1.38215005 |
| 152 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.35412109 |
| 153 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.35115040 |
| 154 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.34520228 |
| 155 | Metatarsus adductus (HP:0001840) | 1.34148184 |
| 156 | Nephronophthisis (HP:0000090) | 1.33291050 |
| 157 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.32319280 |
| 158 | Abnormal biliary tract morphology (HP:0012440) | 1.32275514 |
| 159 | Acute encephalopathy (HP:0006846) | 1.32222164 |
| 160 | Acute necrotizing encephalopathy (HP:0006965) | 1.31752972 |
| 161 | Abnormality of the pons (HP:0007361) | 1.31057861 |
| 162 | Limb-girdle muscle weakness (HP:0003325) | 1.30362657 |
| 163 | Progressive muscle weakness (HP:0003323) | 1.28867853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.22545266 |
| 2 | NEK1 | 3.10175538 |
| 3 | PHKG1 | 2.98766762 |
| 4 | PHKG2 | 2.98766762 |
| 5 | PNCK | 2.92443558 |
| 6 | LATS2 | 2.91305020 |
| 7 | PDK4 | 2.69060591 |
| 8 | PDK3 | 2.69060591 |
| 9 | MARK1 | 2.60695018 |
| 10 | TRIB3 | 2.58634485 |
| 11 | LMTK2 | 2.48185226 |
| 12 | OBSCN | 2.43029776 |
| 13 | LATS1 | 2.40380728 |
| 14 | MAP2K4 | 2.20890091 |
| 15 | PINK1 | 2.08550514 |
| 16 | PKN2 | 2.00648107 |
| 17 | EEF2K | 1.99516257 |
| 18 | WNK3 | 1.68628881 |
| 19 | EPHB2 | 1.64867279 |
| 20 | MAP3K9 | 1.58894553 |
| 21 | PAK3 | 1.58311398 |
| 22 | DMPK | 1.57067877 |
| 23 | FRK | 1.56855261 |
| 24 | PTK6 | 1.47774861 |
| 25 | ERBB4 | 1.45760047 |
| 26 | TLK1 | 1.40739010 |
| 27 | KSR2 | 1.37556838 |
| 28 | PDK2 | 1.33169877 |
| 29 | TSSK6 | 1.27981405 |
| 30 | BCKDK | 1.27108451 |
| 31 | TTK | 1.26209081 |
| 32 | MINK1 | 1.24233371 |
| 33 | LIMK1 | 1.24066730 |
| 34 | SIK1 | 1.23473547 |
| 35 | MST1R | 1.22052954 |
| 36 | CAMK1G | 1.21149384 |
| 37 | MAP3K2 | 1.19973490 |
| 38 | FER | 1.19081870 |
| 39 | RIPK1 | 1.18357963 |
| 40 | NTRK1 | 1.16326333 |
| 41 | PAK6 | 1.14037878 |
| 42 | MAP3K4 | 1.13216851 |
| 43 | RET | 1.13101496 |
| 44 | TNIK | 1.13002727 |
| 45 | STK3 | 1.07166407 |
| 46 | TRPM7 | 1.06528451 |
| 47 | PDGFRA | 1.06395108 |
| 48 | PIK3CA | 1.05400811 |
| 49 | BMPR1B | 1.04778343 |
| 50 | NME1 | 1.04092398 |
| 51 | MAPKAPK3 | 1.02533489 |
| 52 | TAOK1 | 1.02040760 |
| 53 | NEK2 | 1.01124581 |
| 54 | MAP2K1 | 1.00933928 |
| 55 | PIK3CG | 0.99508499 |
| 56 | MUSK | 0.98106733 |
| 57 | PBK | 0.96224947 |
| 58 | CCNB1 | 0.95869318 |
| 59 | STK38L | 0.95199859 |
| 60 | MAP3K7 | 0.94266840 |
| 61 | DDR2 | 0.93530703 |
| 62 | NEK9 | 0.93322650 |
| 63 | CHEK2 | 0.92509636 |
| 64 | GRK1 | 0.90393518 |
| 65 | WEE1 | 0.89109871 |
| 66 | ABL2 | 0.86287290 |
| 67 | STK16 | 0.85629870 |
| 68 | MAP3K5 | 0.83608213 |
| 69 | PRKAA1 | 0.82182181 |
| 70 | FGFR4 | 0.81876932 |
| 71 | MOS | 0.81687980 |
| 72 | ERBB3 | 0.81520329 |
| 73 | PTK2 | 0.79593154 |
| 74 | BMX | 0.78067801 |
| 75 | MAPK13 | 0.77627856 |
| 76 | MAP2K6 | 0.77190878 |
| 77 | TESK1 | 0.76411736 |
| 78 | ROCK1 | 0.76348766 |
| 79 | WNK4 | 0.76006883 |
| 80 | ICK | 0.74472183 |
| 81 | STK38 | 0.74434317 |
| 82 | MYLK | 0.72607094 |
| 83 | MAP3K6 | 0.71981151 |
| 84 | CDC7 | 0.71035392 |
| 85 | MAP2K3 | 0.70869234 |
| 86 | EPHA2 | 0.70851099 |
| 87 | PRKAA2 | 0.70443292 |
| 88 | PAK2 | 0.69993200 |
| 89 | MAPKAPK5 | 0.69602893 |
| 90 | BUB1 | 0.69014339 |
| 91 | ERBB2 | 0.68872302 |
| 92 | AKT3 | 0.68683518 |
| 93 | STK39 | 0.68645575 |
| 94 | MAP3K3 | 0.68588730 |
| 95 | EIF2AK3 | 0.66647468 |
| 96 | BRSK2 | 0.65290501 |
| 97 | MAPK12 | 0.63852350 |
| 98 | OXSR1 | 0.63825229 |
| 99 | KSR1 | 0.60909606 |
| 100 | STK11 | 0.60840023 |
| 101 | MAP3K11 | 0.58340702 |
| 102 | PRKCI | 0.57172065 |
| 103 | CAMK1D | 0.56880447 |
| 104 | CDK8 | 0.56816017 |
| 105 | SRPK1 | 0.56091839 |
| 106 | PLK1 | 0.55537406 |
| 107 | BRAF | 0.55340857 |
| 108 | CSNK1G2 | 0.53419127 |
| 109 | CDK9 | 0.52517384 |
| 110 | SCYL2 | 0.51995655 |
| 111 | NTRK3 | 0.51073937 |
| 112 | DYRK2 | 0.51039185 |
| 113 | CDK14 | 0.50280545 |
| 114 | AURKA | 0.49028704 |
| 115 | CAMK2D | 0.48619847 |
| 116 | TIE1 | 0.47282678 |
| 117 | CAMK2A | 0.47223860 |
| 118 | CAMKK1 | 0.47173167 |
| 119 | GRK5 | 0.46176709 |
| 120 | TGFBR1 | 0.46160349 |
| 121 | PTK2B | 0.45780206 |
| 122 | MET | 0.44925741 |
| 123 | FGFR1 | 0.44635392 |
| 124 | MTOR | 0.44430635 |
| 125 | TAF1 | 0.44192906 |
| 126 | ILK | 0.44011892 |
| 127 | AURKB | 0.43566956 |
| 128 | FGFR2 | 0.43322386 |
| 129 | * CSNK1E | 0.43253286 |
| 130 | STK24 | 0.43132567 |
| 131 | PRKACB | 0.42933101 |
| 132 | PLK3 | 0.42895555 |
| 133 | ZAK | 0.42797669 |
| 134 | DAPK2 | 0.42660712 |
| 135 | EPHA3 | 0.41868373 |
| 136 | CDK6 | 0.41810516 |
| 137 | CDK12 | 0.40568068 |
| 138 | MAPK4 | 0.40388304 |
| 139 | CAMK2G | 0.40090737 |
| 140 | RPS6KA2 | 0.40051152 |
| 141 | PRKD1 | 0.40012674 |
| 142 | ALK | 0.39930510 |
| 143 | NTRK2 | 0.39782696 |
| 144 | * PRKACG | 0.39763823 |
| 145 | MAPK15 | 0.39421936 |
| 146 | AKT2 | 0.39050993 |
| 147 | PDPK1 | 0.38552082 |
| 148 | PRKG1 | 0.38521682 |
| 149 | CASK | 0.38383198 |
| 150 | TYRO3 | 0.38247484 |
| 151 | PRKCG | 0.37896469 |
| 152 | * GSK3A | 0.37771886 |
| 153 | WNK1 | 0.37118019 |
| 154 | ADRBK1 | 0.36138258 |
| 155 | CHEK1 | 0.35628680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.37267976 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35683661 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.99399637 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75025384 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.56922868 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41844146 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27197098 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.26374453 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.21116178 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.03869443 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.03839325 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.00724599 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.96935913 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96739189 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90124252 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85763899 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83965636 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83056948 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.82451658 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.81879380 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.66702643 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.63015474 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58323308 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56996436 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.53350561 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53042220 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49116484 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.48007811 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.47941760 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46643282 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46497691 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46362648 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45426206 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44637324 |
| 35 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.43221107 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.42576265 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.41966468 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36817699 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28491319 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.26857547 |
| 41 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.22741757 |
| 42 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.17334837 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.16638375 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.14548803 |
| 45 | Protein export_Homo sapiens_hsa03060 | 1.14021989 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13277322 |
| 47 | RNA transport_Homo sapiens_hsa03013 | 1.12043785 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08692667 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.08207394 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08159242 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 1.07529812 |
| 52 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.06641691 |
| 53 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.06483814 |
| 54 | RNA polymerase_Homo sapiens_hsa03020 | 1.06402091 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06207150 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 1.04696266 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04692221 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03646755 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03405795 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98862469 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98148671 |
| 62 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97951608 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97734486 |
| 64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.94547205 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90891919 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90850424 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.89778484 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89059113 |
| 69 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.88962542 |
| 70 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.85849097 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85618006 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84902372 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83648118 |
| 74 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.81653547 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.78335222 |
| 76 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.77245863 |
| 77 | ABC transporters_Homo sapiens_hsa02010 | 0.77120147 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76200725 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75150147 |
| 80 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72110521 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71043223 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70711485 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70524648 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69937136 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68646585 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68632638 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68595244 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.67767747 |
| 89 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65965420 |
| 90 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65923778 |
| 91 | Homologous recombination_Homo sapiens_hsa03440 | 0.65599302 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64328551 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63523066 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.60363986 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57868589 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57823208 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57587522 |
| 98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57348982 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.56997194 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56423441 |
| 101 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56295440 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55167379 |
| 103 | Cell cycle_Homo sapiens_hsa04110 | 0.54758658 |
| 104 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54622616 |
| 105 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.54188573 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52433971 |
| 107 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49878214 |
| 108 | Melanoma_Homo sapiens_hsa05218 | 0.48305912 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46860317 |
| 110 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44219328 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.43641611 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41736560 |
| 113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39596120 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38368608 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37290450 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.36817693 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36339671 |
| 118 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35164541 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33990206 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33678209 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.32621754 |
| 122 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32131753 |
| 123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.31259583 |
| 124 | Axon guidance_Homo sapiens_hsa04360 | 0.30957121 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30925985 |
| 126 | Renin secretion_Homo sapiens_hsa04924 | 0.30624033 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.29953643 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29341767 |
| 129 | Focal adhesion_Homo sapiens_hsa04510 | 0.28683941 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27020855 |
| 131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25623380 |
| 132 | Bladder cancer_Homo sapiens_hsa05219 | 0.24379278 |
| 133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.24230450 |
| 134 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.24219889 |
| 135 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24164694 |
| 136 | Gap junction_Homo sapiens_hsa04540 | 0.23653962 |
| 137 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.22825781 |
| 138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22275531 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.22096100 |

